• Nifty %
  • Sensex %
  • Nifty Bank %
  • Equity
  • Mutual Fund
  • Currency
  • Commodity
  • Derivative
  • Research

MARKET SNAPSHOT

  • INDIAN
  • GLOBAL
  • CURRENCY
  • COMMODITIES
  • TOP GAINERS
  • TOP LOSERS

MARKET SNAPSHOT

  • INDIAN
  • GLOBAL
  • BSE SENSEX
    1. 1443442
    2. -965.56
    3. 1443 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • Last Update:09 Nov,2017
  • Show All
  • CURRENCY
  • COMMODITIES
  • YEN TO IND
    1. 1443442
    2. -965.56
    3. 1443 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • BSE SENSEX
    1. 1443442
    2. -1000.56
    3. 30000 %
  • Last Update:09 Nov,2017
  • Show All
  • TOP GAINERS
  • TOP LOSERS
  • 52 WEEK HIGH
  • 52 WEEK LOW
healthcare pharmaceucitals
Back

Healthcare & Pharmaceucitals

Ayushman Bharat, the flagship scheme of the Modi government is likely to remain a key focus in the government’s second term as well. It may propose to introduce and increase health budget to upgrade Ayushman Bharat or the Pradhan Mantri Jan Arogya Yojana. With the urgent need to add bed capacity for the nation, the deduction under section 35AD may be increased from 100% to 150% of capital expenditure incurred by institutions engaged in building and operating a hospital with at least 100 beds. These developments may be positive for the companies like Thyrocare,
Dr. LalPathlabs, Apollo Hospitals and Narayana Hrudayalaya.

Back

X

Provided credentials already exist.

INVEST IN MUTUAL FUNDSPARTNER WITH US